World Health Organization. (2020). International Classification of Diseases 10th Revision (ICD-10). Geneva: WHO Press.
[2]
American Cancer Society. (2021). Bladder Cancer Facts and Statistics. Atlanta: American Cancer Society.
[3]
Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424.
[4]
National Comprehensive Cancer Network. (2022). NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version 2.2022. Plymouth Meeting: NCCN.
[5]
Indonesian Ministry of Health. (2020). Panduan Nasional Penanganan Kanker di Indonesia. Jakarta: Kemenkes RI.
[6]
Ferlay, J., et al. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941-1953.
[7]
Surveillance, Epidemiology, and End Results Program. (2021). Cancer Statistics Review: Bladder Cancer. Bethesda: National Cancer Institute.
[8]
European Association of Urology. (2021). EAU Guidelines on Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer. Arnhem: EAU Guidelines Office.
[9]
Kemenkes RI. (2019). Riset Kesehatan Dasar 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.
[10]
International Agency for Research on Cancer. (2020). Bladder Cancer: Risk Factors and Prevention. Lyon: IARC Monographs.